Lonza Inc.

Lonza is the global leader in the life science markets: Microbial Control and Custom Manufacturing, with state-of-the-art products, services, and research.

As a worldwide leader supplying the pharmaceutical and biotechnology industries with biopharmaceuticals, Lonza furnishes different markets with state-of-the-art products, services, and research. Our customers range from professionals within the pharmaceutical, biotechnology, academic, and government research industries to manufacturers of consumer and health products, distributors, formulators, and service companies.

Lonza's Market Offerings:

BioResearch: Groundbreaking research and quality control laboratory testing systems that include tools for microbial detection tests.

Pharma & Biotech: Emerging and established innovators of novel therapeutics with manufacturing expertise, advanced technologies, and high-quality products.

Nutrition: Branded, scientifically proven ingredients for human and animal nutrition.

Microbial Control: Hygiene products helping to protect the health and wellbeing of people and animals around the world which are used to disinfect and sanitize schools, food processing plants, restaurants, grocery stores, hospitals, homes and more.

Personal Care: Unique products and services to meet personal care development needs.

Agriculture: Custom manufacturing of active ingredients and agrochemical intermediates for agrochemical companies.

Materials Science: Supporting many materials science industries with valued products and services.

Water Treatment: Technologies to control the growth of microorganisms such as bacteria, algae and fungi in everything from pools and spas to drinking water to food hygiene and industrial cooling, papermaking and related markets.

Wood Protection: Wood treating chemicals and related wood preservation technologies

Founded in 1897 in the Swiss Alps, Lonza today is one of the world's leading life sciences companies. We harness science and technology to create products that make people's lives safer and healthier and that enhance the overall quality of life and well-being. Our products range from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from Vitamin B compounds and other nutritional ingredients to the custom development of agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.

Lonza today is a truly global company, with more than 40 manufacturing and R&D facilities and 10,000 employees worldwide. The company is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. The core competencies that span these segments are advanced manufacturing and quality control systems, superior regulatory expertise, in-depth market knowledge, and extensive technical customer-support and R&D capabilities.

Lonza continues to leverage its core strengths in innovation, technology, and regulatory expertise while capturing cross-divisional synergies in manufacturing, research, and sales. By clicking the Factsheet will find a detailed breakdown of our management committees, business divisions, group functions, key figures, and our sales by operating segments.

In Facts & Figures you will learn more about Lonza as well as our extraordinary team, awards, and successes.

Committed to Good Corporate Governance.

Lonza Group Ltd, a holding company under Swiss law, is fully committed to good corporate governance. As an internationally active company, we comply with all local rules and regulations of the countries in which we work. Our governance is measured against the SIX Swiss Exchange's "Directive on Information relating to Corporate Governance." The Board of Directors reviews these principles and rules regularly to adhere to best practices. In March 2009, Lonza joined the United Nations Global Compact, a strategic policy initiative for businesses. As a consequence of the decision taken on 18 December 2009 by the Sanction Commission of SIX Exchange Regulation 5, the internal instructions and procedures that should ensure compliance with the stock exchange rules and regulations were thoroughly analyzed together with an external consultant. In 2010, any flaws detected were corrected by adapting directives and procedures.

The Lonza brand will strengthen all offerings. All offerings will strengthen the Lonza brand.

Our Vision

We strive to be the leading supplier using science and technology to improve the quality of life.

Our Mission

We work with passion, using advanced technologies, to transform life science into new possibilities for our customers

We focus on the customers' R&D and manufacturing needs in clearly defined life-science markets
We make optimal use of and further develop high-tech biology and chemical technology platforms
We sustain operational excellence in innovation, leadership, operations and all processes that are valued by our customers.

Our Values

Influential - our know-how and experience make us the leading expert in many areas. We influence positive outcomes and we influence our communities with our work.

Enterprising - a step beyond entrepreneurship, we are enterprising throughout our organization. In every step, in every process, in every function, we are continuously looking at ways to improve, innovate, and add increasing value.

Connected - We are a team of trusting people, connected with each other within Lonza, and can do more together than we can do individually. We are connected with our customers and stakeholders and they trust us and our solutions that contribute to better results.

Our Brand Themes

We make it happen.

We are closer than you think.

We care about the next generation.

Our sharpened 5-year strategy will see the Group remain firmly focused on life sciences with excellence in products and services which are complex, regulated and come in contact with the human body. Lonza will move further into nutrition and microbial control to balance volatility in the CMO business. Moving closer to the customer will allow the Group to capture more of the value chain and mitigate the impact of raw materials price increases - by moving active ingredients focus toward formulation and distribution. Lonza will continue to leverage its core strengths in innovation, technology and regulatory expertise while capturing cross-divisional synergies in manufacturing, research and sales. The Group will move decisively into the growth economies of emerging markets and better balance its currency exposure by improving its natural currency hedge. As part of this strategy, innovation partnerships and alliances with industry leaders are likely to increasingly occur. Financially, in addition to driving growth and reducing volatility, the strategy should result in lesser reliance on capex-driven growth, greater return on operating assets and stronger cash flow.